Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

384 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Reply by Authors.
Minervini A, Campi R, Lane BR, De Cobelli O, Sanguedolce F, Hatzichristodoulou G, Antonelli A, Noyes S, Mari A, Rodriguez-Faba O, Keeley FX, Langenhuijsen J, Musi G, Klatte T, Roscigno M, Akdogan B, Furlan M, Karakoyunlu N, Marszalek M, Capitanio U, Volpe A, Brookman-May S, Gschwend JE, Smaldone MC, Uzzo RG, Carini M, Kutikov A. Minervini A, et al. Among authors: gschwend je. J Urol. 2020 Mar;203(3):503-504. doi: 10.1097/JU.0000000000000591.02. Epub 2019 Nov 27. J Urol. 2020. PMID: 31774733 No abstract available.
Intraoperative frozen section monitoring during nerve-sparing radical prostatectomy: evaluation of partial secondary resection of neurovascular bundles and its effect on oncologic and functional outcome.
Hatzichristodoulou G, Wagenpfeil S, Weirich G, Autenrieth M, Maurer T, Thalgott M, Horn T, Heck M, Herkommer K, Gschwend JE, Kübler H. Hatzichristodoulou G, et al. Among authors: gschwend je. World J Urol. 2016 Feb;34(2):229-36. doi: 10.1007/s00345-015-1623-3. Epub 2015 Jun 23. World J Urol. 2016. PMID: 26100945
Extended versus limited pelvic lymph node dissection during bilateral nerve-sparing radical prostatectomy and its effect on continence and erectile function recovery: long-term results and trifecta rates of a comparative analysis.
Hatzichristodoulou G, Wagenpfeil S, Wagenpfeil G, Maurer T, Horn T, Herkommer K, Hegemann M, Gschwend JE, Kübler H. Hatzichristodoulou G, et al. Among authors: gschwend je. World J Urol. 2016 Jun;34(6):811-20. doi: 10.1007/s00345-015-1699-9. Epub 2015 Sep 29. World J Urol. 2016. PMID: 26420596
Chromogranin A and neurone-specific enolase serum levels as predictors of treatment outcome in patients with metastatic castration-resistant prostate cancer undergoing abiraterone therapy.
Heck MM, Thaler MA, Schmid SC, Seitz AK, Tauber R, Kübler H, Maurer T, Thalgott M, Hatzichristodoulou G, Höppner M, Nawroth R, Luppa PB, Gschwend JE, Retz M. Heck MM, et al. Among authors: gschwend je. BJU Int. 2017 Jan;119(1):30-37. doi: 10.1111/bju.13493. Epub 2016 Apr 27. BJU Int. 2017. PMID: 27037533
The Phase 3 COU-AA-302 Study of Abiraterone Acetate Plus Prednisone in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Stratified Analysis Based on Pain, Prostate-specific Antigen, and Gleason Score.
Miller K, Carles J, Gschwend JE, Van Poppel H, Diels J, Brookman-May SD. Miller K, et al. Among authors: gschwend je. Eur Urol. 2018 Jul;74(1):17-23. doi: 10.1016/j.eururo.2017.08.035. Epub 2017 Sep 20. Eur Urol. 2018. PMID: 28939004 Clinical Trial.
384 results